Fda Setting the Bar to Low? Cause for Medical Malpractice in New York

One of the FDA’s responsibilities is to regulate and control prescription drugs available on the market. However recently questions have risen as to whether the FDA is setting the proper controls on how drugs get approval. The FDA in the past has had numerous drugs that have had to be recalled because they were causing negative side effects for people taking the drugs. Serious complications have risen and just to make a few kidney failure from the use of Trasylol, birth defects and suicidal tendencies from Paxil which have both been proven to be life threatening. Recently the drug Zetia/Vytorin has been on the chopping block for failure to provide evidence that the drug actually reduces heart attacks or cardiovascular disease. Sales of this drug have reached over $5 million last year alone. Prescriptions are being filled at an alarming rate causing the drug to maintain high profits.

However, what we do not know about this drug is if it is actually proven to reduce the risks that it claims. The FDA approved the drug back in 2002 based on small testing methods that did not last over 3 months in duration. “Researchers reported last month that patients in three clinical trials had a 40 percent higher chance of dying from cancer if they took Vytorin instead of a sugar pill or another medicine, although the leader of that study says the finding might be due to chance.” This shows how the FDA has been eager to get drugs such as Vytorin on the market in a hurry. The evidence supports the fact that the FDA is also being pressured by pharmaceutical companies to get their drugs on the market. The whole basis of this kind of pressure is obviously profits. Profits are what drive an economy, but when the economy is in such distress from being pelted with lawsuit after lawsuit it is bound to collapse. When one industry is taking advantage of another the lesser of the two is bound to fall causing the other one to come down with it. Medical malpractice in New York has reached a peak due in large part to the pressures put on medical professionals, including the FDA, from large pharmaceutical companies.

Suggestions that the FDA might be too loose on the allowance of new drugs on the market may be true; however they are not the only ones to blame. The fact that pharmaceutical companies and doctors are supporting these happenings places the blame on all three parties. Medical malpractice in New York has become such a problem that both patients and doctors are threatening to go elsewhere for their medical needs. If this keeps occurring within our economy it will weaken until the medical industry in New York is obsolete. If you have witnessed these types of behaviors that have directly and negatively affected you, contact a medical malpractice New York Lawyer as soon as possible. For you may be qualified to receive compensation for medical expenses and other expenses that you might have incurred.